Article in Journal of the American Society of Nephrology : JASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors.
Yoshio FunahashiDepartment of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0003-3609-0266
Jessica F HebertDepartment of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0003-2433-8359
Adam MunhallDepartment of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0002-1960-5486
Daiki AomuraDepartment of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0002-9892-8426
Kevin G BurfeindDepartment of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0002-4192-6753
Elizabeth D NguyenDepartment of Pediatrics, University of Washington, Seattle, Washington.ORCID 0000-0002-2798-6581
Tahnee GroatDepartment of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0002-8002-7742
Megan N NickersonDepartment of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0001-9334-2656
Mahaba B EiwazDepartment of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0001-6085-0304
Jonathan W NelsonDivision of Nephrology, and Hypertension, Department of Medicine, Keck School of Medicine, University of Southern California. Los Angeles, California.
Nicole K AndeenDepartment of Pathology, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0002-4882-6640
Motoko YanagitaDepartment of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-0339-9008
Susan B GurleyDivision of Nephrology, and Hypertension, Department of Medicine, Keck School of Medicine, University of Southern California. Los Angeles, California.
Michael P HutchensDepartment of Anesthesiology and Perioperative Medicine, Oregon Health and Science University, Portland, Oregon.ORCID 0000-0001-8583-1812
Funding
University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Oregon Clinical and Translational Research Institute KL2 SupplementKL2TR002370 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Catherine Lee Hough · 2017 to 2026
$10.1M
Oregon Clinical and Translational Research Institute TL1 ProgramTL1TR002371 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALLISON Deborah FRYER, JESSINA C MCGREGOR · 2017 to 2026
$6.2M
Actions of Angiotensin II Along the Nephron to Regulate Blood PressureR01DK098382 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI GURLEY, SUSAN BAILEY · 2014 to 2025
$3.8M
Renal Pericytes as a Target for Angiotensin II Signaling in HypertensionK01DK121737 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI NELSON, JONATHAN W · 2020 to 2024
$669k
American Heart Association 20CDA35320169American Heart Association 24CDA1269598BLRD VA I01 BX004288NCATS NIH HHS KL2 TR002370NCATS NIH HHS KL2TR002370NCATS NIH HHS TL1 TR002371NCATS NIH HHS TL1TR002371NCATS NIH HHS UL1 TR001414NIDDK NIH HHS K01 DK121737NIDDK NIH HHS K01DK121737NIDDK NIH HHS R01 DK098382NIDDK NIH HHS R01DK098382US Department of Defense W81XWH2010196US Department of Veterans Affairs I01BX004288
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
cardiovascular eventscell and transport physiologyCKDendocytosishypertension and cardiorenal disorders
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cardiac LIM Protein, Kidney Fibrosis, and Vascular Change after Acute Cardiorenal Syndrome. · full record | OpenQuestion